MOHIT KHERA to Adult
This is a "connection" page, showing publications MOHIT KHERA has written about Adult.
Connection Strength
0.635
-
Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie's Disease: Clinical Predictors and Side Effect Profile. Urol Pract. 2025 Jan; 12(1):168-175.
Score: 0.056
-
Differential Gene Expression in Post-Finasteride Syndrome Patients. J Sex Med. 2021 09; 18(9):1479-1490.
Score: 0.045
-
Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk. J Sex Med. 2021 01; 18(1):83-98.
Score: 0.043
-
An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? Eur Urol Focus. 2019 Jul; 5(4):536-538.
Score: 0.039
-
Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression. J Sex Med. 2018 05; 15(5):786-788.
Score: 0.036
-
Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. J Sex Med. 2018 02; 15(2):148-158.
Score: 0.036
-
Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population. J Sex Med. 2017 01; 14(1):88-97.
Score: 0.033
-
Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 07; 91(7):908-26.
Score: 0.032
-
The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. J Sex Med. 2015 Nov; 12 Suppl 7:464-7.
Score: 0.030
-
Depression is correlated with the psychological and physical aspects of sexual dysfunction in men. Int J Impot Res. 2013 Sep; 25(5):194-9.
Score: 0.025
-
12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med. 2013 Mar; 125(2):8-18.
Score: 0.025
-
Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37.
Score: 0.024
-
The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male. 2012 Mar; 15(1):14-21.
Score: 0.023
-
Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 Nov; 8(11):3204-13.
Score: 0.023
-
Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011 Sep; 186(3):1005-11.
Score: 0.023
-
Penile constriction devices: a randomized survey study to compare preferences between two medical-grade devices. J Sex Med. 2025 Jan 03; 22(1):43-50.
Score: 0.014
-
Is urgent surgical management necessary for priapism in pediatric patients with hematologic conditions? J Pediatr Urol. 2022 08; 18(4):528.e1-528.e6.
Score: 0.012
-
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):630-637.
Score: 0.011
-
Unilateral Corporal Cavernosum Partial Thrombosis: A Challenging Presentation and Management. Urology. 2021 06; 152:12-14.
Score: 0.011
-
Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf). 2019 12; 91(6):885-891.
Score: 0.010
-
Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019 May 30; 5(1):38.
Score: 0.010
-
Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012. Aging Male. 2019 Mar; 22(1):45-54.
Score: 0.009
-
Diagnosing secondary hypogonadism: important consequences for fertility and reversibility. BJU Int. 2016 Apr; 117(4):552-4.
Score: 0.008
-
The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data. J Urol. 2016 Feb; 195(2):427-33.
Score: 0.008
-
Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014 Nov; 11(11):2764-71.
Score: 0.007
-
Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45.
Score: 0.007
-
Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Postgrad Med. 2013 Mar; 125(2):19-29.
Score: 0.006
-
The treatment of hypogonadism in?men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24.
Score: 0.006
-
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging. 2012; 7:321-30.
Score: 0.006
-
Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS). Pain Med. 2012 May; 13(5):688-98.
Score: 0.006
-
Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011 May; 123(3):17-27.
Score: 0.006
-
Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular. 2009 Nov-Dec; 17 Suppl 3:S129-36.
Score: 0.005